Obesity trials in Germany

In Germany 86 Also abroad 1939

86 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Not yet taking people in Germany
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER‑OSA 1)
Where
Bamberg, Bochum, Duesseldorf, Hamburg, Hanover, Ibbenbüren, Karlsruhe, Oldenburg in Holstein, Schleswig
Age
18 years and over
People
30
Run by
Pfizer Inc.
See details and how to join2026-526327-22-00 · EU 2026-526327-22-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Bad Oeynhausen, Erlangen, Essen, Frankfurt Am Main, Hamburg, Hof, Köln, Munich, Münster, Pirna
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Bad Oeynhausen, Erlangen, Essen, Frankfurt Am Main, Gelnhausen, Hamburg, Hof, Köln, Münster, Pirna
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
No phaseNot yet taking people in Germany
Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
Where
Düsseldorf
Age
18 years and over
People
94
Run by
German Diabetes Center
See details and how to joinNCT07926152
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Bad Oeynhausen, Luebeck, Oldenburg in Holstein, Schwerin
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Where
Berlin, Bochum, Hanover, Hohenmölsen, Karlsruhe, Leipzig, Obertshausen, Offenbach Am Main, Oldenburg in Holstein, Ratingen
Age
18 years and over
People
2,001 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00
Phase 3Not yet taking people in Germany
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Where
Berlin, Duisburg, Elsterwerda, Frankfurt, Hamburg, Münster, Oldenburg in Holstein
Age
18 years and over
People
1,408 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07919405
Phase 2Taking people
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Where
Essen, Leipzig, Muenster, Oldenburg in Holstein
Age
18 years to 75 years
People
200 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Berlin, Bünde, Essen, Hamburg, Muenster, Münster, Oldenburg in Holstein
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Where
Bochum, Buende, Duisburg, Hamburg, Karlsruhe, Leipzig, München, Offenbach Am Main
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Where
Bamberg, Berlin, Essen, Hanover, Karlsruhe, Marburg, Oldenburg, Schwerin
Age
18 years and over
People
800 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Duisburg, Hamburg, Münster, Offenbach, Oldenburg
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Germany
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Berlin, Bochum, Cologne, Essen, Gladbeck, Hamburg, Leipzig, Lübeck, Offenbach, Oldenburg, Ratingen
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 3Not yet taking people in Germany
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Berlin, Bochum, Elsterwerda, Frankfurt am Main, Lübeck, Mannheim, Offenbach Am Main, Oldenburg in Holstein, Pohlheim, Stuttgart, Villingen-Schwenningen, Weinheim
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
Where
Berlin, Essen, Hamburg, Hanover, Karlsruhe, Oldenburg in Holstein
Age
18 years and over
People
120 worldwide
Run by
Amgen Inc.
See details and how to join2025-522699-94-00 · EU 2025-522699-94-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Munich, Offenbach Am Main, Schwerin, Speyer, Wiesbaden, Zwenkau
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Not yet taking people in Germany
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Where
Bad Homburg, Erlangen, Freiburg im Breisgau, Leipzig, Mainz
Age
18 years and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00
Phase 3Taking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
Where
Berlin, Essen, Hanover, Leipzig
Age
18 years and over
People
932 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526172-23-00 · EU 2026-526172-23-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Bad Berka, Bad Neustadt an der Saale, Bad Segeberg, Berlin, Bonn, Detmold, Dortmund, Dresden, Düsseldorf, Frankfurt am Main, Fulda, Göttingen, Hamburg, Haßloch, Heidelberg, Homburg, Jena, Kaiserslautern, Leipzig, Leverkusen, Mainz, Mannheim, Minden, München, Offenbach, Papenburg, Regensburg, Schwäbisch Hall, Siegen, Ulm, Wermsdorf
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Offenbach
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Where
Bad Berka, Bad Neustadt A.D.Saale, Bad Segeberg, Berlin, Bonn, Detmold, Dortmund, Dresden, Duesseldorf, Frankfurt am Main, Frankfurt Am Main, Fulda, Goettingen, Hamburg, Hassloch, Heidelberg, Homburg, Jena, Kaiserslautern, Leipzig, Leverkusen, Mainz, Mannheim, Minden, Munich, Offenbach Am Main, Papenburg, Regensburg, Schwäbisch Hall, Siegen, Ulm, Wermsdorf
Age
18 years and over
People
2,787 worldwide
Run by
Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00
Phase 3Not yet taking people in Germany
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Where
Berlin, Bochum, Cologne, Dresden, Fulda, Hamburg, Hanover, Karlsruhe, Leipzig, Muenster, Munich, Naunhof, Oldenburg in Holstein, Pirna, Witten
Age
18 years and over
People
3,000 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00
Phase 3Taking people
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
Where
Ulm
Age
2 years and over
People
4 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07220772 · EU 2024-518674-14-00